Myristoyl pentapeptide-17 e dua na peptide bulabula vakatabakidua na kena ituvatuva ka synthesized me wali kina na tubu sega ni rauta ni mata ni mata/ulu vakayago ..
E vu mai na dua na . 14-18 asidi amino tikitiki ni protein ni tamata e salavata kei na KAP5-1., e lako curuma na N-ivakatakilakila mirisitoila kei na C-iotioti veimaliwai; oqo e vakalevutaka na kena veimama ni bula, vakatara na kena curu vakadodonu na tamata kuliniyago Na veitiki ni sela.
Myristoyl pentapeptide-17 sa ikoya ena gauna oqo e dua vei ira na peptides kaukauwa cake ni veivakabulabulataki e vakayagataki me vakauqeta na tubu ni mata ., vakalevutaki ena vuqa na iyaya totoka ..
Kena ikabakaba
Myr-Lys-Leu-Ala-Lys-Lys-NH2.
Naba ni CAS
959610-30-1
Fomula ni Molikula
C41H81N9O6.
Bibi ni Molikula
796.16
Na vakadidike e baleta na Myristoyl-17
1.Na iwalewale taumada ni bula
Vakavinakataki ni veisoliyaki ni KGF(Na ka e vakavuna na tubu ni yago), VEGF(Na ka e vakavuna na tubu ni salanidra) kei asidi lisofosfatidiki (LPA) is facilitated within these cells, prolonging the hair growth cycle.
Anti-inflammatory properties are also exhibited, making it suitable for sparse eyebrows, and as an adjunct treatment of Alopecia androgénica; itaba ni qase around the eyes being a primary concern.
Veivakatorocaketaki follicular blood circulation is another key effect – enhanced blood flow to the hair follicles means increased nutrient and oxygen delivery, creating an ideal nutritional environment for eyelash growth.
2.Vakatulewataki ni keratina ivakamacala ni gene
The active fragment mentioned above retains the core function of the original KAP proteins(Keratin Associated Proteins).
Binding to cationic amino acid transporters, transcription and subsequent synthesis of KAP5-1 and Type I keratins (31 being the most well documented) is upregulated.
Thickening of the hair shaft cortex is the physical manifestation of this process, eyelash resilience being significantly increased.
3.Veivakatorocaketaki veisoliyaki lailai/ivurevure ni kakana
Myristoyl pentapeptide-17 estimula na veitiki ni yago me sereki VEGF-A kei Na yavu ni tubu ni fibroblast(bFGF se FGF2.).
Na totolo ni kena curu yani na membrane e vakavuna na sala lailai ni kuliniyago vakalevutaki ni sala, vakavinakataki na drodro ni dra, vakatorocaketaki veimaliwai veisautaki ni kakana kei na vakalevutaki ni kakana ki na follicle ..
Na veivakacacani ni veivakacacani e tiki kece ni dua na levu cake ., ivakarau ni veivakabulabulataki vakataki koya ni vakavinakataki ni itataqomaki ni kuli.
Vakalekalekataka na gauna ni vakacegu ni follicle ni drauniulu kei na kena vakatorocaketaki na bula ni mata, sa ikoya na itinitini ni veika e cakava na Myristoyl Pentapeptide-17.
COA
HPLC
MS





